Hot Topics August 15, 2024: HS Updates, Emergency Contraception and Isotretinoin

08/26/24 • 3 min

In a new AARS video dermatologist Andrea Zaenglein, MD, FAAD and OB/Gyn Sarah K. Horvath, MD, MSHP, FACOG discuss patient counseling and recommendations for prescribing emergency contraception for patients on isotretinoin. Crown Laboratories, which owns the PanOxyl line of acne care products, plans to acquire Revance Therapeutics. New data for izokibep, a novel IL-17A inhibitor, for HS, and more.

The American Acne and Rosacea Society (AARS) is the only professional society focused on acne, hidradenitis suppurativa, and rosacea. Support AARS by becoming a member!

The American Acne and Rosacea Society (AARS) is the only professional society focused on acne, hidradenitis suppurativa, and rosacea. Support AARS by becoming a member!

Previous Episode

Hot Topics June 6 2024: Highlights from the 11th Annual AARS Scientific Symposium

As part of its ongoing efforts to support research and share scientific knowledge about acne, hidradenitis suppurativa (HS), and rosacea, the American Acne and Rosacea Society (AARS) hosted its 11th Annual Scientific Symposium on May 15, 2024. The AARS was thrilled to welcome the attendees of the annual Society for Investigative Dermatology meeting to hear researchers from across the US present recent advancements in dermatological research focusing on acne, HS, and rosacea. Plus, this edition of Hot Topics in print covers a new study comparing clascoterone with retinoids and new data from the BE HEARD I and BE HEARD II studies of bimekizumab in HS.

The American Acne and Rosacea Society (AARS) is the only professional society focused on acne, hidradenitis suppurativa, and rosacea. Support AARS by becoming a member!

Next Episode

Cannabis-Related Product Use Among Patients with Hidradenitis Suppurativa: Insights from Adam Friedman, MD

New research offers new insights on the use of cannabis among patients with hidradenitis suppurativa. The findings don't surprise Adam Friedman, MD, Professor and Chair of Dermatology and Director of the HS program at GW School of Medicine and Health Sciences. He shares his insights on the paper, published in the Journal of Cutaneous Medicine and Surgery, and offers tips for counseling and managing patients. Dr. Friedman is a Director of the American Acne and Rosacea Society.

The American Acne and Rosacea Society (AARS) is the only professional society focused on acne, hidradenitis suppurativa, and rosacea. Support AARS by becoming a member!